Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia
Jazyk angličtina Země Itálie Médium electronic
Typ dokumentu dopisy
PubMed
32499245
PubMed Central
PMC7927996
DOI
10.3324/haematol.2020.249094
PII: haematol.2020.249094
Knihovny.cz E-zdroje
- MeSH
- akutní lymfatická leukemie * diagnóza epidemiologie genetika MeSH
- lidé MeSH
- mutace MeSH
- pre-B-buněčná leukemie * diagnóza epidemiologie genetika MeSH
- prognóza MeSH
- transkripční faktor Zeb2 MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- Názvy látek
- transkripční faktor Zeb2 MeSH
- ZEB2 protein, human MeSH Prohlížeč
CLIP Childhood Leukemia Investigation Prague Prague Czech Republic
Department of Pediatric Hematology and Oncology Hannover Medical School Hannover Germany
Department of Pediatrics University Medical Center Schleswig Holstein Kiel Germany
Division of Pediatric Oncology University Children's Hospital Zürich Switzerland
German Cancer Consortium and German Cancer Research Center Heidelberg Germany
Zobrazit více v PubMed
Goossens S, Peirs S, Van Loocke W, et al. . Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia. Blood. 2017;129(8):981-990. PubMed PMC
Goossens S, Radaelli E, Blanchet O, et al. . ZEB2 drives immature Tcell lymphoblastic leukaemia development via enhanced tumourinitiating potential and IL-7 receptor signalling. Nat Commun. 2015; 6:5794. PubMed PMC
Li JF, Dai YT, Lilljebjorn H, et al. . Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci U S A. 2018; 115(50):E11711-E11720. PubMed PMC
Liu YF, Wang BY, Zhang WN, et al. . Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine. 2016; 8:173-183. PubMed PMC
Schroeder MP, Bastian L, Eckert C, et al. . Integrated analysis of relapsed B-cell precursor acute lymphoblastic leukemia identifies subtype-specific cytokine and metabolic signatures. Sci Rep. 2019; 9(1):4188. PubMed PMC
Zhang J, McCastlain K, Yoshihara H, et al. . Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat Genet. 2016; 48(12):1481-1489. PubMed PMC
Hirabayashi S, Ohki K, Nakabayashi K, et al. . ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. Haematologica. 2017;102(1):118-129. PubMed PMC
Gu Z, Churchman M, Roberts K, et al. . Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. Nat Commun. 2016;7:13331. PubMed PMC
Gu Z, Churchman ML, Roberts KG, et al. . PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019; 51(2):296-307. PubMed PMC
Lilljebjorn H, Henningsson R, Hyrenius-Wittsten A, et al. . Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun. 2016;7:11790. PubMed PMC
Roberts KG, Li Y, Payne-Turner D, et al. . Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014; 371(11):1005-1015. PubMed PMC
Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. . A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009; 10(2):125-134. PubMed PMC
Mullighan CG, Su X, Zhang J, et al. . Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360(5):470-480. PubMed PMC
Zaliova M, Kotrova M, Bresolin S, et al. . ETV6/RUNX1-like acute lymphoblastic leukemia: a novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype. Genes Chromosomes Cancer. 2017;56(8):608-616. PubMed
Zaliova M, Stuchly J, Winkowska L, et al. . Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort. Haematologica. 2019;104(7):1396-1406. PubMed PMC